Onkologická Lekáreň s.r.o.Active

IČO 51166518limited liability company (s.r.o.)Founded 2017Nitra

Key figures

44 974 €-51,4%
Revenue 2025
-16,3%
Average annual change 2020–2025
0100 k200 k300 k400 k202020212022202320242025

Key figures

2025

Dividends

calculated
2025

No dividends were distributed.

History
dividends other decrease in equity
20250 €
20240 €
20230 €
20220 €+109 999 € other
20210 €
Balance sheet structure
Current assetsFixed assetsLiabilitiesEquity
0100 k200 k300 k202020212022202320242025
Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)64 846374 17380 53992 48744 974
Profit for the reporting year-94 264-43 627-29 96345-37 694
Retained earnings of previous periods-31 283-125 546810-18 105-6 060
Total assets178 14762 27772 95226 40550 953
Total liabilities163 885201 64186 08910 58850 331
Total equity14 262-139 364-13 13715 817622
Calculated dividends00000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements10

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Summary: Onkologická Lekáreň s.r.o.

Overview

Onkologická Lekáreň s.r.o. (IČO 51166518) is a limited liability company (s.r.o.). The company was incorporated in 2017 and has existed for 9 years. Registered office according to the register: Nitra. Main activity according to the Statistical Office: maloobchod so športovými potrebami (SK NACE 4763). Size category by number of employees: 3–4 employees.

People

The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 5 000 €.

Financial results

Revenue for 2025 was 44 974 €, down 51,4 % on the previous year (92 487 €). From 2020 to 2025, revenue fell by an average of 16,3 % per year. This is the lowest revenue in the reported years (2020–2025). 2025 ended with a loss of 37 694 €. The company was profitable in 2 of the 6 reported years. Personnel costs for 2025 were 45 679 €. At the end of 2025 the company had total assets of 50 953 € and equity of 622 € (equity ratio 1,2 %).

Points to note

At the end of 2025 the ratio of equity to liabilities was below 8 to 100; under Section 67a of the Slovak Commercial Code the company may be considered a company in crisis.

Sources and freshness

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 7. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Onkologická Lekáreň s.r.o. – IČO 51166518 — icoprofil.sk